Dr. David Abrams' career focuses on systems and social learning frameworks to inform population health enhancement. He has experience in testing theory, research design, measuring mechanisms of behavior change and outcome, and evaluating clinical trials (behavioral and pharmacological). His interests span topics from basic bio-behavioral mechanisms and clinical treatments to policy across risk factors and behaviors (e.g. tobacco/nicotine; alcohol, obesity, co-morbidity of medical and mental health), disease states (cancer; cardiovascular; HIV-AIDS), levels (biological, individual, organizational, worksite, community, global, and internet based), populations and disparities. His interests converge in the domain of implementation science to cost-efficiently inform evidence-based public health practice and policymaking.
Through transdisciplinary and translational research strategies, Dr. Abrams provides scientific leadership in tobacco control. His current focus is in strengthening global and United States tobacco and nicotine management strategies. Deaths of 1 billion smokers are estimated by 2100 caused overwhelmingly by use of combustible (smoked) tobacco products, not nicotine. Harm minimization is a key overarching systems strategy to speed the net public health benefit of emergent disruptive technologies for cleaner nicotine delivery. The goal is more rapid elimination of preventable deaths, disease burdens, and the widening gap in health disparities driven disproportionately by disparities in smoking.
Dr. Abrams was a professor and founding director of the Centers for Behavioral and Preventive Medicine at Brown University Medical School. He then directed the Office of Behavioral and Social Sciences Research at the National Institutes of Health (NIH). Until 2017, he was Professor of Health Behavior and Society at Johns Hopkins Bloomberg School of Public Health and the founding Executive Director of the Schroeder National Institute of Tobacco Research and Policy Studies at Truth Initiative (formerly the American Legacy Foundation).
Dr. Abrams has published over 250 peer reviewed scholarly articles and been a Principal Investigator on numerous NIH grants. He is lead author of The Tobacco Dependence Treatment Handbook: A Guide to Best Practices. He has served on expert panels at NIH and National Academies of Sciences, Engineering and Medicine on Obesity, Alcohol Misuse and Ending the Tobacco Problem: A Blueprint for the Nation. He has also served on the Board of Scientific Advisors of the National Cancer Institute (NIH-NCI) and was President of the Society of Behavioral Medicine.
David Abrams on Tobacco Harm Reduction - Interviews, Letters, Op-Eds, Speeches, Videos, etc.
- 2019, Sep 20 - Interview - Public health expert worries e-cigarette panic is ruining "single biggest public health opportunity" in 120 years
- 2018, Feb 9 - Article - NTRI’s Abrams: Smokers should use e-cigarettes if they can’t quit completely
- 2018, Oct 20 - Interview - DISTORTED HARMS | Teen VAPING & NICOTINE use is “OVERBLOWN”— Dr. David Abrams
- 2017, Dec 20 - Letter to the FDA - Re: a framework for considering the appeal of flavors in nicotine products
David Abrams on Tobacco Harm Reduction - Sampling of Studies, Reviews, Papers, etc.
- 2018, Jan 11 - Review Paper - Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives (Alternative Link)
Article, Blogs, Stories About Abrams
- 2018, Oct 24 - Planet of the Vapes - The Growth of David Abrams